Press release
2023-02-10
CTC expands its Site Network and launches a new clinic at GoCo Health Innovation City in Gothenburg on October 1st
CTC, a full-service contract research organization based in Sweden, announces the expansion of its in-house Site Network with the launch of a new clinic in Gothenburg on October 1st. This new facility will be equipped with the latest technology for conducting clinical trials and will have 8 beds for early phase clinical trials and a high capacity for out-patient visits. The Gothenburg clinic is located in the GoCo area and is easily accessible for study participants.
The Gothenburg clinic will be part of CTC’s ClinSmart concept that connects all CTC’s sites through common routines, virtual/digital tools, and processes. The ClinSmart concept, implemented at all of CTC’s sites, will ensure seamless integration of multiple units and a consistent quality of services.
“The launch of the Gothenburg clinic is an exciting milestone for CTC as it expands our geographic coverage area and provides us with an opportunity to reach more patients and healthy volunteers in southwestern Sweden. The site will be an important part of our full-service proof-of-concept/Phase II service offering”, says Anders Millerhovf, CEO at CTC.
CTC’s Site Network currently consists of five fully equipped clinical research units located in Uppsala, Stockholm, and Linköping. With the addition of the Gothenburg clinic, CTC’s Site Network will have a total of 60 beds for early clinical trials and will support the clinical conduct of studies in all phases of development as well as medical device investigations. The expanding Site Network creates new possibilities for the conduct of patient studies in Sweden, which will strengthen Sweden’s position as a leading Life Science nation.
Clinical Trial Consultants
CTC’s mission is to facilitate clinical and translational research by providing its customers with a collaborative, proactive and flexible approach. With over 130 employees, CTC provides personalized service with a focus on efficient information exchange, minimum response time, and swift issue resolution.
In contrast to many other CROs, CTC performs clinical conduct at our own clinical research units – the CTC Site Network – with our own Investigators, Research Nurses and Laboratory personnel.
CTC’s In-house Site Network currently consists of five fully equipped clinical research units located in Uppsala, Stockholm, and Linköping. With the addition of the Gothenburg clinic, CTC’s Site Network will have a total of 60 beds for early clinical trials and will support the clinical conduct of studies in all phases of development as well as medical device investigations.
CTC’s ClinSmart – our concept that connects all CTC’s sites through common routines, virtual/digital tools, and processes. The ClinSmart concept, implemented at all of CTC’s sites, will ensure seamless integration of multiple units and a consistent quality of services.
To facilitate fast and effective clinical trial conduct we have our own Recruitment team that constantly work with renewing our own healthy volunteer and patient database, supporting our Site Network as well as studies conducted at external clinics.
Besides having access to our own qualified and professional on-site staff, we collaborate with specialists in most therapeutic areas and thus reach many different patient groups.
The six state-of-the-art clinical research units, all with overnight capacity, comprise one First-in-Human (FIH) unit at Uppsala University hospital and five Phase 0-IV clinics:
CTC Akademiska, Uppsala:
Our 12-bed, FIH unit, Akademiska, is perfectly located adjacent to the ICU, PET-centre and MRI-facilities at Uppsala University Hospital in Sweden.
Safety always comes first when planning, managing and running a FIH study. CTC has experience in setting up adaptive FIH umbrella protocols including single and multiple ascending dose cohorts, food and drug-drug interaction parts, and patient cohorts. We conduct approximately five FIH studies each year. Being a certified site for early precision QT-assessments (EPQT), we may incorporate this service into your FIH study and provide the possibility for a TQT waiver.
CTC Oscar, Uppsala:
This unit has 24 beds and is, together with CTC’s head office, located next to the Uppsala University hospital. At this research unit we offer Phase 0-IV studies, for example drug-drug interaction, thorough QT, and bioavailability and proof-of-concept studies.
CTC MTC, Uppsala:
This unit is located in proximity to Uppsala University Hospital. With 4 beds and a high capacity for out-patient visits, it is perfectly fitted for multi-centre trials conducted on-site or with a hybrid or virtual design.
CTC Karolinska, Stockholm:
This unit is located close to the Karolinska University Hospital and has 8 beds for conduct of phase I-IV trials and a high capacity for out-patients visits. At this site we have a mix of online staff for virtual visits, site staff for on-site visits as well as home care staff.
CTC Ebbepark, Linköping
Our newest clinic in Linköping with 4 beds is perfectly fitted for multi-centre trials conducted on-site or with a hybrid or virtual design.
CTC GoCo, Gothenburg (opens Oct 01)
Our newest clinic in located at GoCo Health Innovation City in Gothenburg. With 8 beds and a high capacity for out-patient visits, it is perfectly fitted for multi-centre trials conducted on-site or with a hybrid or virtual design.
Besides studies conducted by our in-house physicians, CTC’s Site Network also facilitates the conduct of clinical trials with external Principal Investigators who are given access to all benefits of using a professional research site with established systems and procedures – the ClinSmart Concept. Research Nurses assist with logistics, administration, patient recruitment and clinical conduct.
Sandra Gunnarsson, Director Clinical Research Units
Malin Selin, Director CTC ClinSmart
